Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Zaponex
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zaponex 25mg tablets
0402010C0BDAAAA
|
Zaponex | Clozapine | Central Nervous System | 17 |
|
Zaponex 100mg tablets
0402010C0BDABAB
|
Zaponex | Clozapine | Central Nervous System | 16 |
|
Zaponex 12.5mg orodispersible tablets
0402010C0BDACAH
|
Zaponex | Clozapine | Central Nervous System | 6 |
|
Zaponex 50mg orodispersible tablets
0402010C0BDAEAJ
|
Zaponex | Clozapine | Central Nervous System | 4 |
|
Zaponex 100mg orodispersible tablets
0402010C0BDAFAK
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zaponex 200mg orodispersible tablets
0402010C0BDAGAL
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zaponex 25mg orodispersible tablets
0402010C0BDADAI
|
Zaponex | Clozapine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.